Novavax reported $1.02B in Market Capitalization this February of 2023, considering the latest stock price and the number of outstanding shares.

Trading Economics members can view, download and compare data from nearly 200 countries, including more than 20 million economic indicators, exchange rates, government bond yields, stock indexes and commodity prices.

The Trading Economics Application Programming Interface (API) provides direct access to our data. It allows API clients to download millions of rows of historical data, to query our real-time economic calendar, subscribe to updates and receive quotes for currencies, commodities, stocks and bonds.

Please Paste this Code in your Website
Market Capitalization Change
Adma Biologics ADMA:US USD 478M 89M
Agenus AGEN:US USD 581M 57M
AstraZeneca AZN:LN USD 154.08B 13.26B
Astrazeneca AZN:US USD 171.96B 31.78B
Biocryst Pharmaceuticals BCRX:US USD 2.34B 376M
Dynavax Technologies DVAX:US USD 1.32B 270M
Geron GERN:US USD 884M 299M
GlaxoSmithKline GSK:LN GBP 58.86B 5.75B
Mannkind MNKD:US USD 813M 149M
Merk MRK:US USD 281.3B 63.14B
Minerva Neurosciences NERV:US USD 49M 31M
Moderna Inc MRNA:US USD 46.26B 10.56B
Novartis NVS:US USD 217.36B 33.38B
Novavax NVAX:US USD 1.42B 2.6B
Pain Therapeutics PTIE:US USD 1.68B 550M
Peregrine Pharmaceuticals PPHM:US USD 1.19B 245M
Pfizer PFE:US USD 287.63B 42.03B
Sanofi SAN:FP EUR 99.37B 22.52B
Sarepta Therapeutics SRPT:US USD 9.68B 3.12B
Tg Therapeutics TGTX:US USD 860M 246M